HMGB1 and stroke disorder: Another study has demonstrated that high mobility group box1-specific antibody had little effect on suppressing inflammatory cytokine expression on the first day after stroke onset compared with the Prx- specific antibodies, which can be explained by the fact that the extracellular release of HMGB1 is mostly diminished in the ischemic brain within 6 h after stroke onset[19].